CryoPen, Inc. among 130 companies and technologies seeking capital, acquisition or licensing partners during WBT 2012
SAN DIEGO--(BUSINESS WIRE)-- CryoPen, Inc., developer and maker of the CryoPen® Cryosurgical System, announced today it has been selected to be a presenter at the tenth annual WBT Innovation Marketplace presented by Northrup Grumman taking place October 24 – 26, 2012 at the San Diego Convention Center. CryoPen is among 130 companies and technology innovators from across the globe that were individually chosen by the WBT Selection Committee to present during WBT 2012. Dr. Mike Haas will speak about the CryoPen® Cryosurgical System and discuss future plans for its proprietary platform to some of the country's leading venture capital firms, Fortune 1000 corporate licensees, federal agency representatives and university technology transfer managers.
The CryoPen® Cryosurgical System delivers treatment at -105° Celsius and is intended for use in the ablation of Cervical Intraepithelial Neoplasia (CIN) grades 1 and 2, as well as the ablation of unwanted tissue in the dermatological practice. Traditional cryosurgery requires the use of liquid nitrogen, nitrous oxide, or carbon dioxide. The CryoPen® Cryosurgical System and CryoPen® GY2 Cervical Attachment do not utilize these dangerous substances.
“We are honored to present alongside a wide array of highly regarded researchers and technologists from around the world who are making ground breaking discoveries,” said Dr. Mike Haas, inventor and President of CryoPen. "We look forward to showcasing the CryoPen® Cryosurgical System and helping WBT attendees see first-hand its applicability to women’s health and lesion removal.”
“We are pleased to include CryoPen and its Cryosurgical System in this choice group of emerging companies and technologies to our exclusive forum of institutional investors, angel investors, and corporate licensees,” said Paul Huleatt, CEO, WBT Innovation Marketplace. “We hope CryoPen will join the WBT alumni that have received over $786 million in early and seed stage funding and licensing. One in three WBT presenters goes on to license, secure venture funding or sell their IP outright.”
As with each year previously, the 2012 WBT Innovation Marketplace represents the collaborative, yearlong effort of investors, licensees, and tech commercialization professionals. The WBT is deal-focused and diverse, showcasing companies and technologies that vary by geography, funding source and type of research institution. Participating technologies are selected by and presented to seasoned venture investors and Fortune 500 licensing scouts representing a variety of growth oriented industries.
WBT 2012 will be hosted by the San Diego Regional Economic Development Corporation and CONNECT, an internationally recognized and award winning regional program that catalyzes the creation of innovative technology and life sciences products in San Diego County by linking inventors and entrepreneurs with the resources they need for success.
About CryoPen, Inc.
CryoPen, Inc. is a leading cryosurgery innovator: designing, developing, marketing, and selling its CryoPen® Cryosurgical System and CryoPen® GY2 Cervical Attachment to primary care physicians, gynecologists, dermatologists, internists, pediatricians, and podiatrists. CryoPen, Inc. offers the most advanced, state of the art technology in the field of cryosurgery. CryoPen, Inc. has offices in Corpus Christi and Dallas, Texas. For more information, please visit: www.cryopen.com.
About WBT Innovation Marketplace
The WBT Innovation Marketplace is the world’s premier showcase converging revolutionary new energy, life science, nanotech, material science and information technologies to seed limitless solutions for current market needs. Attendees will experience an unparalleled forum that is both deal-focused and unbiased with regard to geography, funding source or originating research institution.
Additional information can be found by visiting www.wbtshowcase.com.
Source: CryoPen, Inc.